CynergisTek Gains Momentum with its New Biomedical Device Security Risk Assessment Service to Improve Cybersecurity
11 Septembre 2018 - 2:00PM
Business Wire
Cybersecurity Firm Signs on Multiple Leading
Healthcare Organizations for Service; Sees Increasing Demand to
Address Medical Device Security Challenges
CynergisTek (NYSE AMERICAN: CTEK), a leader in healthcare
cybersecurity and information assurance, today announced it began
providing its new Biomedical Device Security Risk Assessment
service to multiple health systems, including a large, 28-hospital
health system. Offered as the first step of its larger managed
BioMedical Device Security service program, the assessment takes an
enterprise approach to reviewing healthcare organizations’ security
and risk management of biomedical and clinical devices to identify
gaps, vulnerabilities, and risks and provides recommendations for
improving overall device security.
Biomedical devices are being introduced into hospitals’ networks
at a rapid pace, resulting in increased vulnerabilities, new threat
vectors, and greater risk to both patient care and patient data. In
response to these new risks, CynergisTek launched the Biomedical
Device Security Risk Assessment service last spring. With this
service, healthcare organizations can take a holistic approach to
assessing medical device management to gain an understanding of the
number of devices and their known risks and vulnerabilities to
develop a more comprehensive security strategy that covers the full
lifecycle of devices.
“If a biomedical device is compromised or taken offline by a
hacker, that poses a significant safety threat as providers may be
unable to deliver the care a patient needs, putting the patient’s
life in danger,” said David Finn, Executive Vice President of
CynergisTek. “Given the crucial role biomedical devices play in
delivering patient care, it is critical that healthcare
organizations take proactive steps to address the risks and
vulnerabilities associated with these devices.”
“We’ve heard loud and clear from our clients that this is a top
concern for them, which prompted us to begin developing a portfolio
of biomedical device security services to solve this problem,” said
Mac McMillan, CEO at CynergisTek. “As healthcare continues to be a
top target for cyberattacks, biomedical devices are an additional
entry point into the network for malicious actors. Our services
will be specifically tailored to provide an end-to-end approach to
device security by identifying, locating, evaluating and mitigating
risk across all devices in use at an organization. We have seen
high demand for this solution because it is the first that combines
technology and process to accurately find and assess these devices
without creating additional risk.”
CynergisTek is developing a comprehensive set of managed
services to ensure security best practices for the planning,
implementation, and ongoing maintenance of an organization's
biomedical device lifecycle management program. From device
acquisition to retirement, CynergisTek’s managed service program
will provide initial one-time services to support program
implementation and optimization activities as well as ongoing
support to ensure a continued focus on addressing new biomedical
device vulnerabilities and risks as they are discovered.
About CynergisTek
CynergisTek is a top-ranked cybersecurity firm dedicated to
serving the information assurance needs of the healthcare industry.
CynergisTek offers specialized services and solutions to help
organizations achieve privacy, security, compliance, and document
output goals. Since 2004, the company has served as a partner to
hundreds of healthcare organizations and is dedicated to supporting
and educating the industry by contributing to relevant industry
associations. The company has been recognized by KLAS in the 2016
and 2018 Cybersecurity reports as a top performing firm in
healthcare cybersecurity as well as the 2017 Best in KLAS winner
for Cybersecurity Advisory Services.
Forward-Looking Statements
This release contains certain forward-looking statements
relating to the business of CynergisTek that can be identified by
the use of forward-looking terminology such as “believes,”
“expects,” “anticipates,” “may” or similar expressions. Such
forward-looking statements involve known and unknown risks and
uncertainties, including uncertainties relating to product/service
development, long and uncertain sales cycles, the ability to obtain
or maintain patent or other proprietary intellectual property
protection, market acceptance, future capital requirements,
competition from other providers, the ability of our vendors to
continue supplying the company with equipment, parts, supplies and
services at comparable terms and prices and other factors that may
cause actual results to be materially different from those
described herein as anticipated, believed, estimated or expected.
Certain of these risks and uncertainties are or will be described
in greater detail in our Form 10-K and Form 10-Q filings with the
Securities and Exchange Commission, which are available at
http://www.sec.gov. CynergisTek is under no obligation (and
expressly disclaims any such obligation) to update or alter its
forward-looking statements whether as a result of new information,
future events or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180911005275/en/
Investor Relations Contact:CynergisTek, Inc.Bryan Flynn,
949-357-3914InvestorRelations@cynergistek.comorMedia
Contact:Aria MarketingDanielle Johns, 617-332-9999
x241djohns@ariamarketing.com
CynergisTek (AMEX:CTEK)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
CynergisTek (AMEX:CTEK)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024